Drug Trial Radar · NCT07116694
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
Jun 19, 2025
Primary completion
Oct 7, 2025
Study completion Oct 7, 2025
Sponsor
- Lead sponsor
- BioXcel Therapeutics IncIndustry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Aug 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluation of severity of psychomotor agitation episodes in patients with Bipolar Disorders, Schizophrenia, Schizoaffective, and Schizophreniform disorders and correlate them with clinician-assessed ratings.
Conditions
- Bipolar I Disorder
- Bipolar II Disorder
- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorders
- Psychomotor Agitation
Interventions
BXCL501 Sublingual FilmDrug
Single dose BXCL501 120 mcg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Informant and Clinician ratings comparisonTime frame: Before and 2 hours after the intervention
- Informant training materials assessmentTime frame: Within 7 days of the intervention
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
BioXcel Clinical Research Site 103
Chino, California
BioXcel Clinical Research Site 105
Oceanside, California
BioXcel Clinical Research Site 102
Orange, California
BioXcel Clinical Research Site 101
St Louis, Missouri
BioXcel Clinical Research Site 106
Las Vegas, Nevada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.